Antiretroviral therapy coverage for PMTCT in El Salvador
El Salvador: Antiretroviral therapy coverage for PMTCT was 66.0% in 2024. ▲ Rising
Antiretroviral therapy coverage for PMTCT in El Salvador, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage for pmtct in El Salvador is 66.0%, measured in 2024.
The figure is down 25.0% on the previous year and down 22.4% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in El Salvador peaked at 90.0% in 2021 and was at its lowest, 0.0%, in 2000.
El Salvador ranks 56th of 84 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Antiretroviral therapy coverage for PMTCT in El Salvador, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 36.0% | — |
| 2003 | 55.0% | +52.8% |
| 2004 | 75.0% | +36.4% |
| 2005 | 72.0% | -4.0% |
| 2006 | 55.0% | -23.6% |
| 2007 | 47.0% | -14.5% |
| 2008 | 50.0% | +6.4% |
| 2009 | 46.0% | -8.0% |
| 2010 | 40.0% | -13.0% |
| 2011 | 49.0% | +22.5% |
| 2012 | 74.0% | +51.0% |
| 2013 | 87.0% | +17.6% |
| 2014 | 85.0% | -2.3% |
| 2015 | 84.0% | -1.2% |
| 2016 | 81.0% | -3.6% |
| 2017 | 84.0% | +3.7% |
| 2018 | 72.0% | -14.3% |
| 2019 | 82.0% | +13.9% |
| 2020 | 71.0% | -13.4% |
| 2021 | 90.0% | +26.8% |
| 2022 | 90.0% | +0.0% |
| 2023 | 88.0% | -2.2% |
| 2024 | 66.0% | -25.0% |
El Salvador compared with similar countries
- El Salvador's 66.0% is below the median for upper middle income countries, which is 79.5%, 83% of the median. (22 countries reporting)
- El Salvador's 66.0% is below the median for Latin America & Caribbean, which is 68.0%, 97% of the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 43.6% | 0.0% | 75.0% | 10 |
| 2010s | 73.8% | 40.0% | 87.0% | 10 |
| 2020s | 81.0% | 66.0% | 90.0% | 5 |
Countries ranked near El Salvador
More health data for El Salvador
- Un projection of annual infant deaths, annual growth rate -1.89 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4574 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,537 deaths per 1,000 people (2090)
- Number of infants who die before age 1 104 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.9135 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0374 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8849 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in El Salvador?
- Antiretroviral therapy coverage for pmtct in El Salvador was 66.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in El Salvador?
- The highest recorded value was 90.0% in 2021.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in El Salvador?
- The lowest recorded value was 0.0% in 2000.
- How does El Salvador rank for antiretroviral therapy coverage for pmtct?
- El Salvador ranks 56th out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in El Salvador?
- Over the last ten years it is down 22.4%. The long-run trend across the full record is rising.
- Where does this El Salvador data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).